Cover Image

Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog : testimony before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives /

Bibliographic Details
Main Author: Denigan-Macauley, Mary (Author)
Corporate Authors: United States. Government Accountability Office (Author), United States. Congress. House. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (sponsoring body.)
Format: Government Document eBook
Language:English
Published: [Washington, D.C.] : United States Government Accountability Office, 2021.
Series:Testimony ; GAO-21-409T.
Subjects:
United States. > Food and Drug Administration > Rules and practice.
COVID-19 (Disease) > Treatment > United States.
COVID-19 Pandemic, 2020- > United States.
Drugs > Inspection > United States.
Drugs > United States > Safety measures.
Drug reimportation > United States.
Online Access:https://purl.fdlp.gov/GPO/gpo152288

Internet

https://purl.fdlp.gov/GPO/gpo152288

Available Online

Holdings details from Available Online
Call Number: GA 1.5/2:GAO-21-409 T
 
Call Number Status Get It
GA 1.5/2:GAO-21-409 T Available